All of the above results suggest that the CSF3R-AS/CSF3R/JAK2/STAT3 positive feedback loop was activated in the sorafenib-resistant cells, and blocking the loop may relieve the sorafenib resistance of HCC. The gene discussed is JAK2; the disease is hepatocellular carcinoma.